Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 12, 2021

SELL
$18.04 - $22.09 $180,400 - $220,900
-10,000 Closed
0 $0
Q1 2021

Apr 29, 2021

BUY
$16.59 - $33.89 $165,900 - $338,900
10,000 New
10,000 $302,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $24.7M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Sentinel Pension Advisors Inc Portfolio

Follow Sentinel Pension Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentinel Pension Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sentinel Pension Advisors Inc with notifications on news.